TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21455785

Group type: EXPERIMENTAL
Intervention: Low-Intensity Laser Therapy (LILT) using combined He-Ne and infrared lasers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 30
Study: 19555315

Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg capsules, three times daily for 14 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 17725186

Group type: EXPERIMENTAL
Intervention: Training program 'I keep cool'
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study: 15167085

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.60 mg/kg b.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11475920

Group type: COMPARATOR
Intervention: Amitriptyline (50-75 mgs/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mgs/day)
Number of subjects: 40
Study: 10450271

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Divalproex
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 7653432

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bethanechol and Metoclopramide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 0
Study: 2167452

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (500 mg/kg weekly to day 90, then monthly to day 360 after transplantation)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group (not given immunoglobulin)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Number of subjects: 382
Study: 376572

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fenoterol
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 22
Study: 30149825

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy - Long (CBT-L)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy - Brief (CBT-B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 100
Study: 28593413

Group type: EXPERIMENTAL
Intervention: Ulinastatin (100,000 units/10 kg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 70
Study: 26222044

Group type: EXPERIMENTAL
Intervention: Naltrexone/bupropion (NB32)
Number of subjects: 3362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3362
Study: 24261187

Group type: EXPERIMENTAL
Intervention: Intravitreal pegaptanib 0.3 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab 1.25 mg
Number of subjects: 28
Study: 21210134

Group type: EXPERIMENTAL
Intervention: Low dose hCG (100 IU/day) with reduced r‐FSH (75 IU) after lead follicle reached 14 mm
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low dose hCG (200 IU/day) with discontinued r‐FSH after lead follicle reached 14 mm
Number of subjects: 90

Group type: COMPARATOR
Intervention: r‐FSH only (control group) until oocyte retrieval
Number of subjects: 90
Study: 19788471

Group type: EXPERIMENTAL
Intervention: Frovatriptan (twice daily)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 16499880

Group type: EXPERIMENTAL
Intervention: ABT-089 2 mg b.i.d.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: ABT-089 4 mg b.i.d.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: ABT-089 20 mg b.i.d.
Number of subjects: 11

Group type: COMPARATOR
Intervention: ABT-089
Number of subjects: 11
Study: 14555796

Group type: EXPERIMENTAL
Intervention: Colorectal cancer patients
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Colon and rectum polyps patients
Number of subjects: 109

Group type: COMPARATOR
Intervention: Colorectal cancer patients, polyps patients, and control group
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Colorectal cancer tissue
Number of subjects: 109
Study: 10772694

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 36
Study: 9025426

Group type: EXPERIMENTAL
Intervention: Simultaneous double electric breast pumping system
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sequential single electric breast pumping system
Number of subjects: 9
Study: 10171162

Group type: COMPARATOR
Intervention: Centrifugal pump (C group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Roller pump (R group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 6835893

Group type: EXPERIMENTAL
Intervention: 2 mg/kg meptazinol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3 mg/kg meptazinol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 4 mg/kg meptazinol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All doses of meptazinol
Number of subjects: 9
Study: 3514702

Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream for 1 week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream for 2 weeks
Number of subjects: 60
Study: 28681572

Group type: EXPERIMENTAL
Intervention: Novel three-month smoking cessation intervention
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Readiness to quit smoking
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Support from educators
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Generic smoking cessation components and education about smoking and RA
Number of subjects: 38
Study: 26674982

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Non-Eicosapentaenoic acid (non-EPA)
Number of subjects: 240
Study: 25541827

Group type: EXPERIMENTAL
Intervention: Sausalin at a dose of 720 mg/day
Number of subjects: 250

Group type: COMPARATOR
Intervention: Ornidazole at a dose of 1500 mg/day
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Sausalin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Ornidazole
Number of subjects: 250
Study: 22973092

Group type: EXPERIMENTAL
Intervention: NVA237 50 μg once daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 20597951

Group type: EXPERIMENTAL
Intervention: Nicotinamide gel 4%
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 8
Study: 18777603

Group type: EXPERIMENTAL
Intervention: Surgery (standard open discectomy)
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Nonoperative care (usual nonoperative care)
Number of subjects: 1191
Study: 15930418

Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 38546

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38546
Study: 12942871

Group type: EXPERIMENTAL
Intervention: Fermented soy milk (200 ml daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (200 ml chemically fermented)
Number of subjects: 44
Study: 10803764

Group type: EXPERIMENTAL
Intervention: Epoietin alfa (Group A)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 31
Study: 8636593

Group type: EXPERIMENTAL
Intervention: Routine electrocardiogram (EKG) during follow-up visits
Number of subjects: 71
Study: 1354086

Group type: EXPERIMENTAL
Intervention: Epanolol, 200 mg o.d.
Number of subjects: 173

Group type: COMPARATOR
Intervention: Atenolol, 100 mg o.d.
Number of subjects: 173
Study: 6230888

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zimeldine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30616140

Group type: EXPERIMENTAL
Intervention: Low-charge electrotherapy (LCE), administered three times a week, approximately 2.8 Joules
Number of subjects: 12

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 12
Study: 29416219

Group type: EXPERIMENTAL
Intervention: Low-level pressure support (PSV) up to 7 cmH2O
Number of subjects: 520

Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 520
Study: 27412415

Group type: EXPERIMENTAL
Intervention: BCG revaccination after isoniazid preventive therapy (IPT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: BCG revaccination without prior IPT
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BCG revaccination
Number of subjects: 72

Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 72
Study: 24903113

Group type: EXPERIMENTAL
Intervention: Pain coping skills training program delivered by trained physical therapists
Number of subjects: 222
Study: 22826368

Group type: EXPERIMENTAL
Intervention: Trained teachers using language modification techniques
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Trained students with language impairment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group of untrained teachers
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group of students with language impairment
Number of subjects: 43
Study: 21076381

Group type: EXPERIMENTAL
Intervention: Belatacept (more intensive regimen)
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Belatacept (less intensive regimen)
Number of subjects: 1209

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 1209
Study: 18718427

Group type: EXPERIMENTAL
Intervention: PISA-velocity-time integral (VTI)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: simplified PISA
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: M-mode PISA
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: serial PISA
Number of subjects: 73
Study: 16048149

Group type: EXPERIMENTAL
Intervention: Formulas supplemented with both n-3 and n-6 LCPUFA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulas with n-3 LCPUFA for preterm infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feeding n-3 LCPUFA to preterm infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulas providing both n-3 and n-6 LCPUFA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feeding more than 0.2% DHA and 0.3% AA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term feeding study of preterm infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LCPUFA intake in the range provided by human milk
Number of subjects: 0
Study: 14528526

Group type: EXPERIMENTAL
Intervention: Mind-body training program
Number of subjects: 128

Group type: COMPARATOR
Intervention: Education support group (control)
Number of subjects: 128
Study: 10999678

Group type: EXPERIMENTAL
Intervention: PDA ligation under fentanyl anesthesia (15 microg/kg)
Number of subjects: 7
Study: 8867680

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback training (visual training)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 55
Study: 1512330

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (rt-PA)
Number of subjects: 1786
Study: 6147551

Group type: EXPERIMENTAL
Intervention: Zinc acetate 600 mg a day for 7 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30860003

Group type: EXPERIMENTAL
Intervention: Noom Coach for Bariatric Health
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 40
Study: 30113122

Group type: COMPARATOR
Intervention: Exercise only group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Exercise and protein supplementation group
Number of subjects: 81
Study: 26748391

Group type: EXPERIMENTAL
Intervention: Diet and exercise program + placebo
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Glucosamine sulphate
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Diet and exercise program + glucosamine sulphate
Number of subjects: 407
Study: 24672331

Group type: EXPERIMENTAL
Intervention: Standard combined group (S‐C group)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Intensive combined group (I‐C group)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin group (I‐A group)
Number of subjects: 208
Study: 23290037

Group type: EXPERIMENTAL
Intervention: Roxithromycin disperse tablet 0.15 g every day and ambroxol hydrochloride tablet 90 mg 3 times a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ambroxol hydrochloride tablet 90 mg 3 times a day
Number of subjects: 50
Study: 20117105

Group type: EXPERIMENTAL
Intervention: Post-captopril active renin concentration (ARC)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Post-captopril plasma renin activity (PRA)
Number of subjects: 114
Study: 20103914

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with vascular occlusion (LIO)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Dynamic balance exercise (DBE)
Number of subjects: 51
Study: 15692221

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg b.i.d. for 4 days
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Ibuprofen 80 mg b.i.d. for 4 days
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 11823660

Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) during a hand-tapping task in CADASIL patients
Number of subjects: 16

Group type: COMPARATOR
Intervention: Functional MRI (fMRI) during a hand-tapping task in healthy controls
Number of subjects: 16
Study: 10423311

Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin high dose (6 g/100 mL over 2 hr, three times a day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin regular dose (6 g/300 mL over 18 hr/day)
Number of subjects: 13
Study: 7557855

Group type: EXPERIMENTAL
Intervention: Interferon alfa 3 mIU three times weekly for 6 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 46
Study: 2164528

Group type: EXPERIMENTAL
Intervention: Enalapril (E) 10 mg orally
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study: 731808

Group type: EXPERIMENTAL
Intervention: Vesical neck closure
Number of subjects: 102

Group type: COMPARATOR
Intervention: Balloon catheter
Number of subjects: 102
Study: 30738995

Group type: EXPERIMENTAL
Intervention: QuantiFERON-TB Gold In-Tube (QFT) testing
Number of subjects: 20486

Group type: COMPARATOR
Intervention: Moderate alcohol consumption (<10 g/day)
Number of subjects: 20486

Group type: EXPERIMENTAL
Intervention: Indeterminate QFT result
Number of subjects: 20486
Study: 28088839

Group type: EXPERIMENTAL
Intervention: TAK-648 (PDE4 inhibitor) at doses of 0.05-0.85 mg in healthy volunteers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAK-648 (PDE4 inhibitor) at a daily dose of 0.1 mg
Number of subjects: 0
Study: 25636072

Group type: EXPERIMENTAL
Intervention: Ivabradine (10 mg twice a day for 6 weeks)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice a day for 6 weeks)
Number of subjects: 33
Study: 22257584

Group type: EXPERIMENTAL
Intervention: Online in-house information literacy tutorial
Number of subjects: 77

Group type: COMPARATOR
Intervention: One hour face-to-face session
Number of subjects: 77
Study: 21859992

Group type: EXPERIMENTAL
Intervention: Tamoxifen with or without octreotide
Number of subjects: 621
Study: 18469148

Group type: EXPERIMENTAL
Intervention: 10 microM ANG II
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Losartan (2 microg/l)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nitro-l-arginine (NLA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: NLA + losartan
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium ascorbate (10 mM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ringer solution
Number of subjects: 8
Study: 16950434

Group type: EXPERIMENTAL
Intervention: Surgical treatment (SEPS combined with superficial vein ligation)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Conservative treatment (ambulatory compression therapy)
Number of subjects: 170
Study: 14501003

Group type: EXPERIMENTAL
Intervention: Hippocampal volume
Number of subjects: 0
Study: 11053939

Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 9094730

Group type: EXPERIMENTAL
Intervention: Pari‐Baby nebulizer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Detergent‐coated Babyhaler
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nebuchamber
Number of subjects: 20
Study: 7903976

Group type: EXPERIMENTAL
Intervention: Simultaneous regimen of zidovudine and didanosine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Alternating regimen of zidovudine and didanosine
Number of subjects: 41
Study: 2498620

Group type: EXPERIMENTAL
Intervention: Kliogest (continuous treatment)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Trisequens (sequential treatment)
Number of subjects: 34
Study: 1091856

Group type: EXPERIMENTAL
Intervention: Intermittent intravenous injection of heparin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of heparin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Heparin with laboratory control (partial thromboplastin time)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Heparin without laboratory control
Number of subjects: 100
Study: 31785505

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) with 100% oxygen during intubation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Bag-valve-mask ventilation for preoxygenation followed by intubation (Control)
Number of subjects: 106
Study: 30889093

Group type: EXPERIMENTAL
Intervention: Low dose of isoflavones (10mg, n = 35)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Medium dose of isoflavones (35mg, n = 37)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: High dose of isoflavones (60mg, n = 29)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall sample (all doses)
Number of subjects: 101
Study: 28817063

Group type: EXPERIMENTAL
Intervention: Dairy diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study: 25953600

Group type: EXPERIMENTAL
Intervention: Novel low energy-dense semi-solid food (0.72kcal/g)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Higher energy-dense semi-solid food (1.57kcal/g)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intermediate version of the test food
Number of subjects: 68

Group type: COMPARATOR
Intervention: Higher energy-dense meal in UK participants
Number of subjects: 68
Study: 23688320

Group type: EXPERIMENTAL
Intervention: Moving Bright, Eating Smart (physical activity and diet) programme
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study: 21552085

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (15 minutes of running/jogging)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (classroom task not preceded by exercise)
Number of subjects: 0
Study: 19725237

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 19
Study: 17024692

Group type: EXPERIMENTAL
Intervention: 0.2 mg DiaPep277
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1.0 mg DiaPep277
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2.5 mg DiaPep277
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15757154

Group type: EXPERIMENTAL
Intervention: Wireless pH-testing system
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional catheter‐based pH-testing
Number of subjects: 41
Study: 11432478

Group type: EXPERIMENTAL
Intervention: Pulsatile pump flow (n = 11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Laminar pump flow (n = 10)
Number of subjects: 21
Study: 8931582

Group type: EXPERIMENTAL
Intervention: Imageable words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-imageable words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreasing semantic association within imageable and non-imageable groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomly linked pairs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closely related pairs
Number of subjects: 0
Study: 1362320

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine alone (group I)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine in combination with HBIG (group II)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 45
Study: 3932033

Group type: EXPERIMENTAL
Intervention: Combined therapy of prednisone, azathioprine, cyclophosphamide, Heparoid Spofa forte ling., Heparin retard Spofa and dipyridamole
Number of subjects: 31

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 31
Study: 31176057

Group type: EXPERIMENTAL
Intervention: Agency (measured using a theory-based measure composed of 23 indicators)
Number of subjects: 2859

Group type: EXPERIMENTAL
Intervention: Agency regarding attitudes about gender norms
Number of subjects: 2859

Group type: EXPERIMENTAL
Intervention: Agency regarding speaking up in public
Number of subjects: 2859
Study: 29654643

Group type: COMPARATOR
Intervention: Sitagliptin 0 mg (placebo)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sitagliptin 25 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg
Number of subjects: 8
Study: 27068582

Group type: EXPERIMENTAL
Intervention: Postoperative patient-controlled intravenous analgesia
Number of subjects: 370

Group type: COMPARATOR
Intervention: Postoperative epidural analgesia
Number of subjects: 370
Study: 24304349

Group type: EXPERIMENTAL
Intervention: 3 months of daily supervised consumption of OMT
Number of subjects: 293

Group type: COMPARATOR
Intervention: 1 month or less of daily supervised OMT, then daily unsupervised consumption
Number of subjects: 293

Group type: COMPARATOR
Intervention: 1 month or less of daily unsupervised consumption
Number of subjects: 293
Study: 22265975

Group type: COMPARATOR
Intervention: Higher placebo adherence (≥75% adherence)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower placebo adherence (<75% adherence)
Number of subjects: 0